U.S. Hormone Replacement Therapy Market Size & Outlook

The hormone replacement therapy market in the United States is expected to reach a projected revenue of US$ 12,064.5 million by 2030. A compound annual growth rate of 5.7% is expected of the United States hormone replacement therapy market from 2023 to 2030.
Revenue, 2022 (US$M)
$7,762.0
Forecast, 2030 (US$M)
$12,574.7
CAGR, 2023 - 2030
6.2%
Report Coverage
U.S.

U.S. hormone replacement therapy market, 2018-2030 (US$M)

U.S.

U.S. hormone replacement therapy market highlights

  • The U.S. hormone replacement therapy market generated a revenue of USD 7,762.0 million in 2022 and is expected to reach USD 12,574.7 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 6.2% from 2023 to 2030.
  • In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
  • Estrogen and Progesterone Replacement Therapy is the most lucrative product segment registering the fastest growth during the forecast period.


Hormone replacement therapy market data book summary

Market revenue in 2022USD 7,762.0 million
Market revenue in 2030USD 12,574.7 million
Growth rate6.2% (CAGR from 2022 to 2030)
Largest segmentEstrogen and progesterone replacement therapy
Fastest growing segmentEstrogen and Progesterone Replacement Therapy
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEstrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy
Key market players worldwideEli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc


Other key industry trends

  • In terms of revenue, U.S. accounted for 36.5% of the global hormone replacement therapy market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 1,007.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormone Replacement Therapy Market Companies

Name Profile # Employees HQ Website

U.S. hormone replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.


Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 54.69% in 2022. Horizon Databook has segmented the U.S. hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. hormone replacement therapy market generated the largest revenue share in North America in 2021. Economic stability of the country and supportive reimbursement policies are contributing to the adoption of expensive therapies.

Better healthcare infrastructure and reimbursement policies are expected to increase the adoption of hormone replacement therapies in the coming years. For instance, around 25% of children receive insurance coverage under the Children's Health Insurance Program (CHIP) for GHD.

However, the percentage of patients with GHD covered under Medicaid is higher than private insurers. According to American Thyroid Association (ATA), thyroid disorders are common conditions in the U.S. More than 12.0% of the population suffers from these conditions in their lifetime.

Reasons to subscribe to U.S. hormone replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. hormone replacement therapy market databook

  • Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. hormone replacement therapy market size, by product, 2018-2030 (US$M)

U.S. Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)

U.S. hormone replacement therapy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more